Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E16.44 EPS (ttm)12.13 Insider Own0.10% Shs Outstand643.95M Perf Week-0.61%
Market Cap128.39B Forward P/E13.67 EPS next Y14.58 Insider Trans-3.49% Shs Float635.91M Perf Month0.94%
Income8.30B PEG3.54 EPS next Q3.27 Inst Own80.00% Short Float1.57% Perf Quarter1.01%
Sales23.32B P/S5.51 EPS this Y7.30% Inst Trans0.15% Short Ratio3.22 Perf Half Y2.31%
Book/sh22.25 P/B8.96 EPS next Y2.42% ROA3.10% Target Price204.57 Perf Year7.75%
Cash/sh46.46 P/C4.29 EPS next 5Y4.65% ROE12.60% 52W Range163.31 - 210.19 Perf YTD2.42%
Dividend5.80 P/FCF18.48 EPS past 5Y14.40% ROI14.00% 52W High-5.14% Beta1.37
Dividend %2.91% Quick Ratio2.80 Sales past 5Y5.80% Gross Margin82.60% 52W Low22.09% ATR5.35
Employees20800 Current Ratio3.10 Sales Q/Q2.30% Oper. Margin43.40% RSI (14)56.87 Volatility1.78% 2.83%
OptionableYes Debt/Eq2.40 EPS Q/Q3.90% Profit Margin9.40% Rel Volume0.88 Prev Close196.78
ShortableYes LT Debt/Eq2.05 EarningsJan 29 AMC Payout135.60% Avg Volume3.11M Price199.38
Recom2.30 SMA203.92% SMA502.85% SMA2005.01% Volume2,755,635 Change1.32%
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Oct-26-17Reiterated RBC Capital Mkts Sector Perform $192 → $188
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Jun-23-17Initiated Deutsche Bank Hold $172
Apr-05-17Downgrade Jefferies Buy → Hold
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jun-29-16Initiated Bernstein Mkt Perform
Feb-25-16Initiated Citigroup Neutral $165
Feb-08-16Reiterated Argus Buy $202 → $185
Jan-15-19 04:18PM  Here's How The Government Shutdown Will Affect These Medical Stocks Investor's Business Daily
03:04PM  3 of the Top Big Pharma Stocks to Buy Now InvestorPlace
Jan-14-19 06:00PM  Democrats target drug prices CNBC Videos
05:52PM  Pharma Stocks Topple After House Dems Launch Drug-Pricing Probe Investor's Business Daily
04:22PM  Will Biogen Jump On This Biotech Stock Amid Buying Spree? Investor's Business Daily
04:08PM  U.S. lawmaker launches investigation into pharma drug pricing Reuters
12:09PM  House Democrats launch drug-pricing probe into a dozen major health-care companies CNBC
09:30AM  Is Amgen (AMGN) Stock Outpacing Its Medical Peers This Year? Zacks
08:39AM  What's in Store for Merck in 2019 After a Solid Run in '18? Zacks
07:07AM  Here's Why You Should Invest in Illumina (ILMN) Stock Now Zacks
Jan-10-19 09:56AM  Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting Zacks
09:30AM  The Zacks Analyst Blog Highlights: Amgen, Broadcom, Starbucks, Citigroup and Carnival Zacks
Jan-09-19 11:35AM  Top Stock Reports for Amgen, Broadcom & Starbucks Zacks
09:50AM  Amgen's Osteoporosis Candidate Evenity Gets Approval in Japan Zacks
07:26AM  Dow Jones Futures Up After China Trade Talks, Trump Speech, Apple Investor's Business Daily
Jan-08-19 04:00PM  EVENITY (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture PR Newswire
02:23PM  Amgen Reduces Price of Repatha Devices GuruFocus.com
11:18AM  Amgen Is a Bright Spot in This Stock Market: Here's How to Play It TheStreet.com
08:15AM  The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase Benzinga
Jan-07-19 06:59PM  Cramer Remix: This chipmaker could have another bad quarterbut it's worth buying now CNBC
06:51PM  'Too many patients' struggling to pay cholesterol drug: A... CNBC Videos
06:40PM  Amgen CEO on cholesterol drug price cut: 'Too many patients' were struggling to pay CNBC
05:13PM  Here's what Amgen's CEO said about the future of the heal... CNBC Videos
04:00PM  Amgen Makes All Repatha® (evolocumab) Device Options Available In The US At A 60 Percent Reduced List Price PR Newswire
02:28PM  U.S. top court rejects Amgen over cholesterol medication patent fight Reuters
02:25PM  U.S. top court rejects Amgen over cholesterol medication patent fight Reuters
10:56AM  As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock InvestorPlace
07:25AM  Report: Exploring Fundamental Drivers Behind Spectrum Brands, Amgen, MSCI, Diamondback Energy, Centene, and Paramount Group New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
07:02AM  5 Things to Watch for at the JPMorgan Healthcare Conference Investopedia
Jan-06-19 06:06PM  Better Buy: Gilead Sciences vs. Amgen Motley Fool
Jan-04-19 04:21PM  REIT Stocks, Medical Stocks Lead New Buys By The Best Mutual Funds In Down Market Investor's Business Daily
12:16PM  Here's Why bluebird bio Shares Got Knocked Down 19.3% in December Motley Fool
06:17AM  Merck Buys NASH Candidate, Keytruda Wins 5 Approvals in Japan Zacks
05:28AM  Amgen Rises 3% Investing.com
Jan-03-19 05:50PM  Amgen (AMGN) Stock Moves -1.52%: What You Should Know Zacks
04:00PM  Amgen To Present At The 37th Annual J.P. Morgan Healthcare Conference PR Newswire
03:03PM  Teva (TEVA) Ends Dispute with Amgen Over Generic Sensipar Zacks
10:29AM  Spectrum Pharma Fully Enrolls 1St Cohort in Poziotinib Study Zacks
10:12AM  Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019? Zacks
07:45AM  Stocks making the biggest moves premarket: AAPL, CELG, JNJ, UBS & more CNBC
07:36AM  The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen Benzinga
03:30AM  Stocks - Apple Plunges in Premarket; Celgene, IZEA Soar; Starbucks, Amgen Drop Investing.com
Jan-02-19 09:33PM  Teva, Amgen end dispute over generic Cinacalcet HCl tablets Reuters
04:28PM  Biopharmas Restrained In Drug Pricing For 2019 With These Exceptions Investor's Business Daily
03:48PM  Cannabis, Migraines, Gene-Silencing: FDA Approvals Hit High Note In 2018 Investor's Business Daily
08:13AM  [$$] Cyber Daily: CEOs Must Step Up The Wall Street Journal
07:28AM  Dow Jones Futures Signal Sell-Off To Open 2019 Stock Market; Trump Says 'Let's Make A Deal' Investor's Business Daily
Dec-31-18 04:56PM  5 Buffett-Munger Stocks Producing High Gains for 2018 GuruFocus.com
Dec-30-18 03:27PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Dec-29-18 08:02AM  Forget GlaxoSmithKline, Eli Lilly Is a Better Big Pharma Stock Motley Fool
Dec-28-18 09:46AM  Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019? Zacks
09:45AM  Spectrum Pharma Files BLA for Neutropenia Candidate Rolontis Zacks
Dec-27-18 01:50PM  The Humira Overhang Cant Cast a Shadow on AbbVie Stock Forever InvestorPlace
09:35AM  AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV InvestorPlace
Dec-26-18 02:08PM  Amgen Rises 3% Investing.com +5.30%
Dec-24-18 05:50PM  Amgen (AMGN) Stock Moves -1%: What You Should Know Zacks
01:13PM  Biotech Buying Spree: Why These 3 Stocks Could Get Deals In 2019 Investor's Business Daily
Dec-21-18 02:52PM  AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib Zacks
08:57AM  Merck's sBLA for Keytruda in Lung Cancer Gets Extended Review Zacks
Dec-20-18 04:14PM  Can This Biotech Stock Rival Amgen In Anemia? Analyst Says Yes Investor's Business Daily
03:50PM  Lilly's Shares Rise on Robust 2019 View, Dividend Hike Zacks
11:56AM  Amgen Applies for Expanded Use of Nplate in US GuruFocus.com
10:18AM  Allergan Drops, Stops Textured Breast Implant Sales in Europe Zacks
10:15AM  Merck's Keytruda Gets FDA Approval for Rare Skin Cancer Zacks
10:13AM  The Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and Incyte Zacks
02:52AM  [$$] Pharma Giants Plan Drug Price Hike: Report The Wall Street Journal
Dec-19-18 07:48PM  Exclusive: Big Pharma returning to U.S. price hikes in January after pause Reuters
06:47PM  Eli Lilly CEO on winning in migraine treatments: 'It's a horse race between three great companies' CNBC
04:00PM  Amgen Submits Supplemental Biologics License Application For Nplate® (romiplostim) PR Newswire
09:17AM  Biotech Stock Roundup: Pipeline Updates From VRTX & AMGN, ADRO Teams Up With LLY Zacks
08:23AM  Forget bluebird bio, Amgen Is a Better Biotech Stock Motley Fool
07:46AM  The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas Benzinga
03:04AM  Molecular Partners agrees cancer immunotherapy deal with Amgen Reuters
Dec-18-18 11:00PM  Amgen And Molecular Partners Announce Strategic Collaboration In Immuno-Oncology PR Newswire
05:50PM  Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know Zacks
05:18PM  Why a kidney disease drug approval in China is just the start for this S.F. company American City Business Journals
04:00PM  Amgen Engages Cambridge Biotech Community To Select 2018 LabCentral Golden Ticket Winners PR Newswire
11:00AM  S&P 500 Q3 2018 Buybacks Surpass $200 Billion Mark for the First Time Ever PR Newswire
10:15AM  Merck's Keytruda Gets EU Nod as Adjuvant Therapy for Melanoma Zacks
09:50AM  Teva Reports Positive Top-Line Data for Migraine Candidate Zacks
09:19AM  Biotech Stocks Made Big Progress Toward Preventing Heart Attacks in 2018 Motley Fool
Dec-17-18 04:56PM  Pfizer's (PFE) Biosimilar of Avastin Gets Positive CHMP Nod Zacks
12:25PM  7 Major Pharmaceutical Stocks to Quarantine Now InvestorPlace
09:00AM  Amgen Submits Biologics License Application for ABP 710 (Biosimilar Infliximab) To US Food And Drug Administration PR Newswire
Dec-15-18 06:30AM  Better Buy: Biogen vs. Amgen Motley Fool
Dec-14-18 04:00PM  FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia PR Newswire
02:11PM  12 Stocks You Should Never Sell Kiplinger
08:23AM  5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019 Zacks
07:59AM  5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride Zacks
Dec-13-18 04:00PM  Amgen And Direct Relief Partner To Aid Cancer Patients In 18 Developing Countries PR Newswire
07:32AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Dec-12-18 05:50PM  Amgen (AMGN) Gains But Lags Market: What You Should Know Zacks
04:51PM  Why Arrowhead Pharmaceuticals Surged 11% Higher Today Motley Fool
12:13AM  Arrowhead Pharmaceuticals (ARWR) Q4 2018 Earnings Conference Call Transcript Motley Fool
Dec-11-18 04:00PM  Amgen And Magellan Rx Management Collaborate To Improve Patient Care For Chronic, Difficult-To-Treat Conditions PR Newswire
09:32AM  Entera shares jump 11.5% on news of collaboration with Amgen MarketWatch
Dec-10-18 04:41PM  Amgen And Lazarex Cancer Foundation Team Up To Allow More Diversity In Clinical Trials PR Newswire
09:13AM  Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend Zacks
Dec-09-18 11:56AM  Amgen Increases Quarterly Dividend GuruFocus.com
Dec-08-18 09:38PM  Is AbbVie Inc (ABBV) A Good Stock To Buy? Insider Monkey
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company's products include Evenity to treat osteoporosis in postmenopausal women; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Repatha to treat coronary diseases; Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Parsabiv to treat secondary hyperparathyroidism (sHPT); and Aimovig for the prevention of migraine. Its products also comprise Blincyto to treat patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia; Kyprolis, a proteasome inhibitor for the treatment of multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound. The company's marketed products include Neulasta, a pegylated protein to treat cancer patients; Aranesp to treat anemia; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; EPOGEN to treat a lower-than-normal number of red blood cells; NEUPOGEN, a recombinant human granulocyte colony-stimulating factor; and IMLYGIC to treat various cancer cells. It serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. The company has collaborative agreements with Pfizer Inc.; UCB; Bayer HealthCare Pharmaceuticals Inc.; The University of Texas MD Anderson Cancer Center; Provention Bio, Inc.; and Molecular Partners AG. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jacks TylerDirectorDec 06Option Exercise82.6020,0001,652,00028,979Dec 10 08:46 PM
Jacks TylerDirectorDec 06Sale195.4120,0003,908,2328,979Dec 10 08:46 PM
Piacquad DavidSVP, Business DevelopmentNov 30Option Exercise54.696,500355,48545,128Dec 03 08:13 PM
Patton Cynthia MSVP & CCONov 29Option Exercise54.691,77797,18423,090Dec 03 08:11 PM
Patton Cynthia MSVP & CCONov 29Sale202.881,777360,52021,313Dec 03 08:11 PM
HENDERSON REBECCA MDirectorAug 10Option Exercise63.113,000189,33016,197Aug 14 08:29 PM
Harper Sean EEVP, Research & DevelopmentJul 16Sale195.711,525298,45856,082Jul 16 08:20 PM
Harper Sean EEVP, Research & DevelopmentJun 12Sale184.271,525281,01257,510Jun 12 07:07 PM
Harper Sean EEVP, Research & DevelopmentMay 14Sale174.101,525265,50359,035May 15 07:52 PM
Piacquad DavidSVP, Business DevelopmentMay 11Option Exercise54.7115,000820,65051,566May 15 07:55 PM
Harper Sean EEVP, Research & DevelopmentApr 12Sale172.681,525263,33756,788Apr 16 07:03 PM
Harper Sean EEVP, Research & DevelopmentMar 16Sale189.751,525289,36965,682Mar 19 08:52 PM
Harper Sean EEVP, Research & DevelopmentFeb 14Sale174.181,525265,62552,089Feb 15 08:57 PM